Other trials also failed to exhibit significant benefits of cholinesterase inhibitors or memantine in improving cognitive decline caused by stroke (Kavirajan and Schneider, 2007; Narasimhalu et al., 2010; McShane et al., 2019). Here, BCHE is linked to stroke disorder.